Trial Outcomes & Findings for Study to Increase Colorectal Screening (NCT NCT02870049)

NCT ID: NCT02870049

Last Updated: 2025-09-04

Results Overview

Completion of any colorectal cancer screening test (FIT, sigmoidoscopy or colonoscopy)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

673 participants

Primary outcome timeframe

23 months

Results posted on

2025-09-04

Participant Flow

Participant milestones

Participant milestones
Measure
Inreach Strategy
This consists of a community health worker-delivered in clinic education regrading CRC screening with a fecal immunochemical test (FIT) kit, and telephone reminders. Inreach strategy: Inreach strategy: In clinic education and delivery of fecal immunochemical test (FIT) kit
Outreach Strategy
This consists of mailed invitations to complete screening with an enclosed fecal immunochemical test (FIT) kit and telephone reminders. Outreach strategy: Outreach strategy: Mailed fecal immunochemical test (FIT) kit and telephone reminders
Both Inreach and Outreach Strategies
This is a combination of the above two strategies: Inreach and Outreach combined. Both Inreach and Outreach strategies: Both Inreach and Outreach strategies: Both In clinic education and delivery of fecal immunochemical test (FIT) kit and Mailed fecal immunochemical test (FIT) kit and telephone reminders
Usual Care
Usual care in the clinic using the fecal immunochemical test (FIT) kit. Usual care: Usual care: FIT kit delivery as part of usual care
Overall Study
STARTED
168
171
167
167
Overall Study
COMPLETED
167
171
166
167
Overall Study
NOT COMPLETED
1
0
1
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Study to Increase Colorectal Screening

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Inreach Strategy
n=167 Participants
This consists of a community health worker-delivered in clinic education regrading CRC screening with a fecal immunochemical test (FIT) kit, and telephone reminders. Inreach strategy: Inreach strategy: In clinic education and delivery of fecal immunochemical test (FIT) kit
Outreach Strategy
n=171 Participants
This consists of mailed invitations to complete screening with an enclosed fecal immunochemical test (FIT) kit and telephone reminders. Outreach strategy: Outreach strategy: Mailed fecal immunochemical test (FIT) kit and telephone reminders
Both Inreach and Outreach Strategies
n=166 Participants
This is a combination of the above two strategies: Inreach and Outreach combined. Both Inreach and Outreach strategies: Both Inreach and Outreach strategies: Both In clinic education and delivery of fecal immunochemical test (FIT) kit and Mailed fecal immunochemical test (FIT) kit and telephone reminders
Usual Care
n=167 Participants
Usual care in the clinic using the fecal immunochemical test (FIT) kit. Usual care: Usual care: FIT kit delivery as part of usual care
Total
n=671 Participants
Total of all reporting groups
Age, Continuous
59.4 years
STANDARD_DEVIATION 6.5 • n=5 Participants
60.0 years
STANDARD_DEVIATION 7.1 • n=7 Participants
60.0 years
STANDARD_DEVIATION 6.5 • n=5 Participants
60.1 years
STANDARD_DEVIATION 6.3 • n=4 Participants
59.9 years
STANDARD_DEVIATION 6.6 • n=21 Participants
Sex: Female, Male
Female
85 Participants
n=5 Participants
86 Participants
n=7 Participants
86 Participants
n=5 Participants
86 Participants
n=4 Participants
343 Participants
n=21 Participants
Sex: Female, Male
Male
82 Participants
n=5 Participants
85 Participants
n=7 Participants
80 Participants
n=5 Participants
81 Participants
n=4 Participants
328 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
167 Participants
n=5 Participants
171 Participants
n=7 Participants
166 Participants
n=5 Participants
167 Participants
n=4 Participants
671 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
0 Participants
n=21 Participants
Region of Enrollment
United States
167 participants
n=5 Participants
171 participants
n=7 Participants
166 participants
n=5 Participants
167 participants
n=4 Participants
671 participants
n=21 Participants

PRIMARY outcome

Timeframe: 23 months

Completion of any colorectal cancer screening test (FIT, sigmoidoscopy or colonoscopy)

Outcome measures

Outcome measures
Measure
Inreach Strategy
n=167 Participants
This consists of a community health worker-delivered in clinic education regrading CRC screening with a fecal immunochemical test (FIT) kit, and telephone reminders. Inreach strategy: Inreach strategy: In clinic education and delivery of fecal immunochemical test (FIT) kit
Outreach Strategy
n=171 Participants
This consists of mailed invitations to complete screening with an enclosed fecal immunochemical test (FIT) kit and telephone reminders. Outreach strategy: Outreach strategy: Mailed fecal immunochemical test (FIT) kit and telephone reminders
Both Inreach and Outreach Strategies
n=166 Participants
This is a combination of the above two strategies: Inreach and Outreach combined. Both Inreach and Outreach strategies: Both Inreach and Outreach strategies: Both In clinic education and delivery of fecal immunochemical test (FIT) kit and Mailed fecal immunochemical test (FIT) kit and telephone reminders
Usual Care
n=167 Participants
Usual care in the clinic using the fecal immunochemical test (FIT) kit. Usual care: Usual care: FIT kit delivery as part of usual care
Screening Completion Rate
46 Participants
88 Participants
132 Participants
131 Participants

Adverse Events

Inreach Strategy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Outreach Strategy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Both Inreach and Outreach Strategies

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Usual Care

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Samir Gupta, MD

UC San Diego

Phone: 07/09/2018

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place